Tesamorelin 5mg

£27.90

Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analogue developed for experimental investigation of pituitary receptor–mediated signalling, growth hormone regulation, and downstream endocrine pathways.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: 901758-09-6
  • Molecular Formula: C221H366N72O67S (net peptide); C223H370N72O69S (mono-acetate salt, as supplied)
  • Amino Acid Sequence: (trans-3-hexenoyl)-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 (N-terminal trans-3-hexenoyl; C-terminal amide)
  • Molecular Weight: 5135.91 (net peptide); 5195.96 (mono-acetate salt, as supplied)

In stock

Add to Cart
OP Labs Tesamorelin 5mg GHRH analogue research peptide lyophilized powder in glass vial
Tesamorelin 5mg
£27.90

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support
  • Guaranteed safe checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides.
  • Batch HPLC tested at ≥ 99% purity.
  • Storage: –20 °C long term; 2–8 °C short term.
  • Sold for research purposes only.

Tesamorelin

Synonyms / Designations: Tesamorelin, TH9507, Growth Hormone–Releasing Hormone (GHRH) analogue
CAS Number: 901758-09-6
Molecular Formula: C223H370N72O69S
Molecular Weight: ~5135.91 g/mol
Peptide Length: 44 amino acids
Peptide Type: Synthetic GHRH analogue
Purity: ≥ 99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Pack Size: 5 mg (typical)
Storage: Desiccated, protected from light, stored at –20 °C or below
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

Tesamorelin is a synthetic peptide analogue of human growth hormone–releasing hormone (GHRH 1–44) designed for experimental investigation of hypothalamic–pituitary signalling and growth hormone regulation. Structural modifications enhance stability relative to native GHRH, making Tesamorelin suitable for controlled laboratory research.

In biochemical and cellular research systems, Tesamorelin interacts with the GHRH receptor expressed on pituitary-derived cells, activating intracellular signalling cascades associated with growth hormone synthesis and secretion. Experimental studies examine receptor binding kinetics, cAMP-mediated signalling, and downstream transcriptional responses under defined exposure conditions. Observed effects are dependent on concentration, duration, and experimental model and are used to investigate GHRH receptor signalling rather than defined physiological outcomes.

Applications in Research

  • As a molecular probe for studying GHRH receptor activation and signalling pathways.
  • Investigation of growth hormone regulatory mechanisms in pituitary cell models.
  • In vitro studies examining peptide stability and receptor selectivity.
  • Use as a reference compound in neuroendocrine and peptide signalling research.

Specifications Summary

Purity: (HPLC): ≥ 99%
Appearance: White to off-white lyophilised powder
Molecular Weight: ~5135.91 g/mol
Peptide Type: Synthetic GHRH analogue
Solubility: Water, buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light
Pack Size: 5 mg

Precautions & Notes

  • Experimental behaviour of Tesamorelin is influenced by receptor expression, peptide concentration, and exposure duration.
  • Buffer composition, pH, and ionic strength may affect peptide stability.
  • Appropriate controls are recommended to distinguish receptor-specific from non-specific effects.
  • Intended strictly for laboratory research use; not for human or veterinary application.

Keywords: Tesamorelin, TH9507, GHRH Analogue, Growth Hormone Regulation, Synthetic Peptide